Neurocrine Biosciences (NBIX) Earnings Date & Reports

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NBIX is expected to report earnings to fall 50.63% to 83 cents per share on April 30

Neurocrine Biosciences NBIX Stock Earnings Reports

Q1'25

Est.

$0.83

Q4'24

Beat

by $0.12

Q3'24

Beat

by $0.29

Q2'24

Beat

by $0.50

Q1'24

Beat

by $0.13

The last earnings report on February 06 showed earnings per share of $1.69, beating the estimate of $1.57. With 1.42M shares outstanding, the current market capitalization sits at 13.72B.

View a ticker or compare two or three

Compare

NBIX